There is growing evidence that peptide hormones from the gut have far-reaching effects on the whole organism. By binding to corresponding receptors in the brain, they can modulate food intake and alter metabolic parameters. However, the role of these…
Bartter syndrome type 3 is the result of several structural variants in the genome. By using long-read sequencing, Janine Altmüller and her team from the Max Delbrück Center, the Berlin Institute of Health at Charité (BIH) and University Hospital…
Reykjavik, Iceland and Berlin, Aug. 18, 2023 — Reykjavik-based drug discovery company, 3Z, and Germany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging…
KNAUER, a pioneering force in the field of high-performance liquid chromatography (HPLC), is proud to announce that for the second consecutive year, it has secured the top position in the prestigious "100 Most Innovative Medium-Sized Businesses“…
KNAUER Wissenschaftliche Geraete GmbH and the Dresden-based start-up company Better Basics Laborbedarf GmbH announce a groundbreaking cooperation. In the future, the combination of the KNAUER AZURA HPLC system and the Better Basics SmartRack®…
BIOTRONIK Announces the Full Market Release of Its Newest Family of Pacemaker and CRT-P Devices, With Patient-Centric Technologies for Better Patient Care and Workflow Simplification
MARC DEWEY from CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN ist nominated with his project "Breaking the Wall to Noninvasive Imaging of Coronary Artery Disease."
GQ Bio Therapeutics GmbH today announced that it has closed a collaboration deal with Pacira BioSciences, Inc. for the development of a manufacturing process for its High-Capacity Adenoviral vector (HCAd) gene therapy product candidate, PCRX-201,…
Combined Company Expected to Expand Access for Patients to Innovative Rehabilitation Technologies for Use in Clinics and the Home
Charles Remsberg Appointed Chief Sales Officer at ReWalk Robotics
Expansion of capabilities provides customised bioconjugation solutions for Pharma and IVD industries
